NANOBIOTIX 31.080 € (+3,74 %)
SERGEFERRARI GROUP 8.000 € (+2,56 %)
SERGEFERRARI GROUP 8.000 € (+2,56 %)
TOTALENERGIES 68.360 € (-1,31 %)
ADYEN 824.900 € (+0,37 %)
EXAIL TECHNOLOGIES 116.700 € (+25,28 %)
CAPGEMINI 89.680 € (+1,33 %)
SHELL PLC 33.700 € (-1,00 %)
BUREAU VERITAS 26.120 € (+0,66 %)
HERMES INTL 1 626.000 € (+0,77 %)
PHILIPS KON 23.890 € (-0,17 %)
SANOFI 75.070 € (+1,78 %)
ASML HOLDING 1 578.200 € (-0,99 %)
BOLLORE 4.100 € (+0,15 %)
VEOLIA ENVIRON. 36.230 € (+0,22 %)
SMCP 5.015 € (+0,30 %)
FLOW TRADERS 25.580 € (-0,93 %)
ASM INTERNATIONAL 948.000 € (-4,34 %)
AYVENS 11.460 € (-0,87 %)
CSG 12.682 € (+2,69 %)
BE SEMICONDUCTOR 282.700 € (-2,21 %)
SCOR SE 31.980 € (+0,50 %)
STMICROELECTRONICS 62.580 € (-3,81 %)
ESSILORLUXOTTICA 168.650 € (+1,54 %)
CRCAM TOURAINE CCI 138.500 € (-0,93 %)
LISI 66.100 € (-0,15 %)
LVMH 495.750 € (+0,27 %)
BOUYGUES 49.750 € (-0,78 %)
DSM FIRMENICH AG 79.980 € (-0,65 %)
NEXANS 141.100 € (-3,75 %)
STELLANTIS NV 5.024 € (-1,95 %)
THALES 216.500 € (-0,87 %)
UMG 18.355 € (+0,71 %)
NN GROUP 76.320 € (-0,29 %)
AHOLD DEL 35.430 € (+0,85 %)
2CRSI 27.520 € (+8,01 %)
SODEXO 51.250 € (-0,10 %)
SOITEC 114.350 € (+1,87 %)
TKH GROUP 43.620 € (+1,73 %)
OVH 13.600 € (+1,49 %)
LNA SANTE 34.000 € (+3,03 %)
EUROFINS SCIENT. 68.960 € (+1,00 %)
BAM GROEP KON 12.550 € (-1,18 %)
AMG 32.900 € (-1,56 %)
CEGEDIM 11.040 € (-1,43 %)
AALBERTS NV 38.980 € (-1,66 %)
DANONE 72.120 € (+3,06 %)
ALSTOM 15.380 € (-1,94 %)
REXEL 36.860 € (-1,18 %)
RELX 27.440 € (-0,29 %)
HAFFNER ENERGY 0.217 € (-2,25 %)
ERAMET 45.160 € (-1,40 %)
SAINT GOBAIN 80.600 € (-1,42 %)
BNP PARIBAS ACT.A 101.120 € (-1,83 %)
RUBIS 31.540 € (+0,64 %)
PERNOD RICARD 65.960 € (-0,06 %)
JCDECAUX 19.050 € (+1,33 %)
SAVENCIA 66.600 € (0,00 %)
AIRBUS 191.900 € (-1,63 %)
ALTEN 53.400 € (+1,81 %) |
18/06/2026 19:00
News releases during takeover bids / Takeover bids Other news releasesThis press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan. Press release French stock market authority clearance decision regarding the mandatory tender offer by CAMLIN FINE SCIENCES on Vinpai sharesRelease of the offer document and other information documentMumbai (India), June 18, 2026 – 18 h CEST CAMLIN FINE SCIENCES LIMITED, a leading Indian group in shelf life solutions for flavour and health & wellness ingredients, listed on the National Stock Exchange of India Ltd and BSE Ltd. in Mumbai India (“CFSL”) reminds that it has completed the acquisition on November 27, 2025, by way of contribution in kind, of a majority stake in the share capital of Vinpai (ISIN: FR001400AXT1; mnémonique : ALVIN) representing 78.68% of share capital and 84.89% of voting rights of Vinpai, at a price of EUR 3.60 per Vinpai share (the “Block Acquisition”) from majority shareholders (the “Sellers”) and proceeded to the conversion of the convertible bonds (the “Convertible Bonds”), allowing it to subscribe to 1,100,000 new ordinary shares of Vinpai, that were issued to it.1 As of today, CFSL holds 83.82% of Vinpai's share capital and 80.85% of its voting rights. CFSL announces that the board of the French Stock Markets Authority (AMF) has issued today its clearance decision on the simplified cash tender offer share capital (offre publique d’achat simplifiée) (the “OPAS”) for the remaining shares of Vinpai’s share capital that are not held by CFSL, at the same price as that of the Block Acquisition, i.e. EUR 3.60 per Vinpai share. The timetable and the terms and conditions of the OPAS are detailed in the offer document of CFSL (the “Offer Document”). In accordance with Article 231-28 of the AMF General Regulation, information relating in particular to the legal, financial and accounting characteristics of CFSL (the “Other Information Document”), together with the Offer Document, have been made available to the public today available on the websites of the AMF (www.amf-france.org), of Camlin Fine Sciences Limited (www.camlinfs.com/) and of Vinpai (https://vinpai-finance.com/fr/). Advisors of CFSL : Presenting institution Legal Advisor F O N T A I N E For further information about CFSL: www.camlinfs.com ContactsCamlin Fine Sciences Limited DisclaimerThis press release does not constitute an offer to sell nor a solicitation of an offer to buy Vinpai shares in any country, nor shall there be any sale of shares in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The distribution of this document may, in certain jurisdictions, be restricted by local legislations. Persons into whose possession this document comes are required to inform themselves about and to observe any such potential local restrictions. This press release constitutes an advertisement and not a prospectus within the meaning of Regulation (EU) no. 2017/1129 of the European Parliament and of the Council of June 14, 2017 (the “Prospectus Regulation”). Any decision to purchase shares must be made solely on the basis of publicly available information on the Company. In France, the issue of bonds convertible into Vinpai shares described above was reserved to an investor falling into the category of beneficiaries defined in the sixteenth resolution of the Company’s general meeting dated June 26, 2024, pursuant to article L. 228-91 of the French commercial code and applicable regulatory provisions. Pursuant to article 211-3 of the French stock market authority (Autorité des marchés financiers) (the “AMF”) general regulations and articles 1(4) and 3 of the Prospectus Regulation, the said issue of convertible bonds will not require the publication of a prospectus approved by the AMF. With respect to Member States of the European Economic Area, no action has been taken or will be taken to permit a public offering of the securities referred to in this press release requiring the publication of a prospectus in any Member State. Therefore, such securities may not be and shall not be offered in any Member State other than in accordance with the exemptions of article 1(4) of the Prospectus Regulation or, otherwise, in cases not requiring the publication by the Company of a prospectus under article 3 of the Prospectus Regulation and/or the applicable regulations in such Member State. This press release and the information it contains are being distributed to and are only intended for persons who are (x) outside the United Kingdom or (y) in the United Kingdom, who constitute “qualified investors” (as this term is defined in the Prospectus Regulation which forms part of domestic law pursuant to European (Withdrawal) Act 2018) and are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”), (ii) high net worth entities and other such persons falling within Article 49(2)(a) to (d) of the Order (“high net worth companies”, “unincorporated associations”, etc.) or (iii) other persons to whom an invitation or inducement to participate in investment activity (within the meaning of Section 21 of the Financial Services and Market Act 2000) may otherwise lawfully be communicated or caused to be communicated (all such persons in (y)(i), (y)(ii) and (y)(iii) together being referred to as “Relevant Persons”). Any invitation, offer or agreement to subscribe, purchase or otherwise acquire securities to which this press release relates will only be available to and engaged with Relevant Persons. This press release is solely intended for Relevant Persons and any person who is not a Relevant Person should not act or rely on this press release or any of its contents. This press release and the information contained therein does not, and will not, constitute an offer of securities for sale, nor the solicitation of an offer to purchase, Vinpai securities in the United States of America or any other jurisdiction where restrictions may apply. Securities may not be offered or sold in the United States of America absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the “Securities Act”). The securities of Vinpai have not been and will not be registered under the Securities Act, and the Company does not intend to conduct a public offering of Vinpai securities in the United States of America. The distribution of this press release may be subject to legal or regulatory restrictions in certain jurisdictions. Any person who comes into possession of this press release must inform him or herself of and comply with any such restrictions. The information contained in this press release does not constitute an offer of securities in the United States of America, in Australia, in Canada, in South Africa, in Japan nor in any other country. This press release shall not be published, transmitted or distributed, directly or indirectly, into the territory of the United States of America, Australia, Canada, South Africa or Japan. Notes
Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière